---
document_datetime: 2023-09-21 22:00:10
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/xaluprine-epar-all-authorised-presentations_en.pdf
document_name: xaluprine-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7072358
conversion_datetime: 2025-12-19 05:44:44.381842
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical form   | Route of administration   | Immediate Packaging     | Content (concentration)   | Pack size                                     |
|------------------|-------------------|------------|-----------------------|---------------------------|-------------------------|---------------------------|-----------------------------------------------|
| EU/1/11/727/001  | Xaluprine         | 20 mg/ml   | Oral suspension       | Oral use                  | bottle (glass); syringe | 100 ml                    | 1 bottle + 1 bottle adaptor + 2 oral syringes |